Back to articles
Comparative guide · 6 min read

Astaxanthin vs Krill oil — antioxidant vs phospholipid omega-3, compared

Updated 2026-05-15 · Reviewed by SupplementScore editors · No sponsorships

Astaxanthin and krill oil get blended together in marketing because both come from the red end of the marine pigment palette — astaxanthin is the carotenoid that turns salmon and krill pink. They answer different questions. Astaxanthin is a lipid-soluble antioxidant studied in skin, eye, and oxidative-stress endpoints. Krill oil is a phospholipid-bound source of EPA and DHA with a small endogenous astaxanthin payload. Picking between them depends on whether you want an antioxidant or an omega-3.

Quick verdict

GoalBetter choiceWhy
EPA/DHA omega-3 sufficiencyKrill oil (or plain fish oil)Krill provides 100–300 mg EPA+DHA per typical 1000 mg capsule; astaxanthin alone provides none.
Skin: UV-related photoaging, dryness, elasticityAstaxanthinSeveral small RCTs at 4–12 mg/day show improvements in skin hydration and elasticity over 8–16 weeks.
Asthenopia / eye strain from screen useAstaxanthinSmall Japanese trials show subjective improvement in accommodation symptoms at 6–12 mg/day.
Triglyceride loweringKrill oilKrill EPA/DHA reduces triglycerides at sufficient combined EPA+DHA dose; astaxanthin alone does not.
Anti-inflammatory broad signalBoth contribute, krill largerEPA-derived resolvins/protectins do most of the work; astaxanthin layered antioxidant.
Cost per day at studied doseAstaxanthin (lower mg)Astaxanthin 12 mg ≈ $0.30/day; krill 1 g ≈ $0.50–1.00/day for typical EPA+DHA delivery.

How they actually work

Astaxanthin — the orientation-flipping carotenoid

Astaxanthin (3,3'-dihydroxy-β,β-carotene-4,4'-dione) is a xanthophyll carotenoid produced by the alga Haematococcus pluvialis; krill, salmon, lobster, and flamingo pink come from eating things that ate this alga. Its polar end-groups let it span lipid bilayers in a way that beta-carotene and vitamin E cannot, sitting half-in-half-out of cell membranes. This gives it both interior (lipid-phase) and exterior (aqueous-phase) antioxidant reach in membranes. Most of the human-trial signal sits in skin (hydration, elasticity, photoaging), eye (asthenopia, retinal blood flow), and exercise-recovery (modest reductions in muscle damage markers).

Krill oil — phospholipid omega-3 with a side of astaxanthin

Krill oil's distinctive property is that 30–60% of its EPA/DHA is bound in phospholipid form rather than triglyceride form. Phospholipid omega-3 is incorporated into red blood cell membranes somewhat more efficiently per gram, though the magnitude of the per-gram advantage is small in head-to-head trials with fish oil. The other distinctive: each krill capsule carries about 50–150 mcg of endogenous astaxanthin (one-tenth to one-hundredth of a standard astaxanthin supplement dose). The omega-3 dose density is lower than fish oil — typical krill 1000 mg delivers 100–300 mg EPA+DHA vs 300–600 mg from concentrated fish oil capsules.

Skin — astaxanthin's clearest signal

Tominaga and others showed astaxanthin 6–12 mg/day for 8–16 weeks improves skin hydration, elasticity, and wrinkle scores in middle-aged women. Effects are modest and require continued dosing. Krill oil does not have a comparable skin-trial dataset. If skin is the goal, astaxanthin is the better-targeted choice. Pair with daily SPF and topical retinoid for the actually-impactful interventions.

Cardiometabolic — krill territory

For triglyceride lowering, krill at sufficient EPA+DHA dose works because EPA+DHA work. The "phospholipid advantage" is real but small (~10–20% better bioavailability per gram). If the goal is cardiometabolic markers and total EPA+DHA exposure, plain concentrated fish oil delivers more EPA+DHA per dollar; krill is a premium option for those who want lower per-capsule dosing or report better tolerability (less "fish burp" reflux).

Sustainability and contamination — context

Antarctic krill fisheries are MSC-certified in major fisheries. Krill is much lower in food-chain heavy-metal accumulation than larger fish. Astaxanthin is now mostly produced from controlled Haematococcus algal cultures; synthetic astaxanthin (from petrochemicals) is used in animal feed but generally not in human supplements.

Practical rule. If you want an omega-3, the question is really "krill vs fish vs algal oil" — and plain concentrated fish oil typically wins on EPA+DHA per dollar. If you want a targeted antioxidant for skin or eye-strain endpoints, astaxanthin at 6–12 mg/day is the cleaner intervention. Combining both is reasonable but not synergistic in any well-documented way.

Dose, form, and timing

Astaxanthin: 6–12 mg/day with a meal containing fat (lipid-soluble carotenoid). Two months is the minimum trial period for skin endpoints. Mild orange-tinge urine at higher doses is harmless.

Krill oil: 1000–2000 mg/day; check the EPA+DHA content (varies 80–300 mg per gram of oil). Take with food. The shellfish source is a contraindication for shellfish allergy.

Safety

Astaxanthin: Well-tolerated. Theoretical mild blood-pressure-lowering effect; caution with antihypertensives at very high doses. Pregnancy/lactation data limited — moderation advised.

Krill oil: Shellfish-allergy contraindication. Mild antiplatelet effect like other omega-3s; discuss with prescriber before surgery or alongside anticoagulants. Phospholipid form may be better tolerated GI-wise.

Who should pick each

Pick astaxanthin if: skin photoaging/hydration is the goal, screen-related eye strain is a daily issue, you want a targeted lipid-soluble antioxidant on top of an existing omega-3.

Pick krill oil if: you tolerate fish oil poorly (reflux, fishy taste), you want a premium omega-3 form with built-in carotenoid, and the higher per-gram cost is acceptable for the lower per-capsule dosing.

What we'd actually take

For most adults pursuing omega-3 status: concentrated fish oil 1–2 g EPA+DHA/day (cheapest) or algal oil for vegans. For skin/eye targets: astaxanthin 8–12 mg/day with a fat-containing meal. Use krill oil if reflux from standard fish oil is a problem.

Sources

Read more: